Literature DB >> 21036726

Isomorph expression of BAG-1 gene, ER and PR in endometrial cancer.

Ourania Porichi1, Maria-Evangelia Nikolaidou, Aikaterini Apostolaki, Niki Arnogiannaki, Issidora Papassideri, Iordanis Chatonidis, Aliki Tserkezoglou, Georgios Vorgias, Dimitrios Kassanos, Efstathia Panotopoulou.   

Abstract

BACKGROUND: BAG-1 isomorphs are regulating proteins with antiapoptotic action in endometrium. ERa and PRA isomorphs seem to have an important role in endometrial cancer. PATIENTS AND METHODS: We investigated the expression of BAG-1, ERa and PRA isomorphs in endometrioid adenocarcinoma and we correlated them with clinicopathological findings of the tumor. Fresh endometrial tissues were obtained from 33 patients with endometrial carcinoma and 191 paraffin-embedded tissues were analyzed by real-time PCR and immunochemistry for BAG-1, ER and PR.
RESULTS: BAG-1 protein is expressed in both nucleus and cytoplasm. Grade 3 tumors were considered to have the highest intensity. Only 4 out of 79 samples showed intense expression of ERa, while 37 samples out of 72 samples strongly expressed PRA.
CONCLUSION: BAG-1 nuclear isomorph appeared more frequently in grade 2 tumors than in grade 1 and 3 tumors, and the cytoplasmatic isomorph was expressed more strongly than the nuclear one.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036726

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

Authors:  Marcela Kazue Hassumi-Fukasawa; Fabiana Alves Miranda-Camargo; Bruna Riedo Zanetti; Denise Faria Galano; Alfredo Ribeiro-Silva; Edson Garcia Soares
Journal:  Pathol Oncol Res       Date:  2012-03-28       Impact factor: 3.201

2.  BAG-1 expression in human meningioma and correlation with clinical characteristics.

Authors:  Kaiyu Zhou; Hanghuang Jin; Ting Zhou; Yongkang Luo
Journal:  Med Oncol       Date:  2013-01-16       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.